Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zaluvida is a life science group that specialized in developing bio-active compounds to tackle global challenges in health and the environment. The company's portfolio included innovative solutions for weight management, such as the medical device I-SENSUS, and the AgTech platform Mootral, designed to reduce methane emissions from livestock. Zaluvida operated under a One Health philosophy, linking human health, animal health, and environmental sustainability. Although the company achieved commercial stage with several products, the corporate entity Zaluvida Corporate AG entered liquidation in Switzerland in late 2019. Its technologies, particularly the Mootral methane-reduction supplement, have continued to gain traction as independent entities or through restructuring. The group's research primarily focused on natural extracts and their application in metabolic health and greenhouse gas mitigation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zaluvida Corporate.